These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9051366

  • 1. Acarbose in the treatment of type I diabetes.
    Hollander P, Pi-Sunyer X, Coniff RF.
    Diabetes Care; 1997 Mar; 20(3):248-53. PubMed ID: 9051366
    [Abstract] [Full Text] [Related]

  • 2. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes.
    Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA.
    Diabetes Care; 1995 Jul; 18(7):928-32. PubMed ID: 7555551
    [Abstract] [Full Text] [Related]

  • 3. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
    Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB.
    Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group.
    Chan JC, Chan KW, Ho LL, Fuh MM, Horn LC, Sheaves R, Panelo AA, Kim DK, Embong M.
    Diabetes Care; 1998 Jul; 21(7):1058-61. PubMed ID: 9653595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.
    Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC.
    Diabetes Care; 1998 Jul; 21(7):1154-8. PubMed ID: 9653611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study.
    Sels JP, Verdonk HE, Wolffenbuttel BH.
    Diabetes Res Clin Pract; 1998 Aug; 41(2):139-45. PubMed ID: 9789720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44).
    Holman RR, Cull CA, Turner RC.
    Diabetes Care; 1999 Jun; 22(6):960-4. PubMed ID: 10372249
    [Abstract] [Full Text] [Related]

  • 15. Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study.
    Hotta N, Kakuta H, Sano T, Matsumae H, Yamada H, Kitazawa S, Sakamoto N.
    Diabet Med; 1993 Mar; 10(2):134-8. PubMed ID: 8458189
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.
    Hoffmann J, Spengler M.
    Diabetes Care; 1994 Jun; 17(6):561-6. PubMed ID: 8082525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The use of acarbose for treating diabetic patients].
    Balabolkin MI, Dedov II, Mkrtumian AM, Ametov AS, Kakhnovskiĭ IM, Chazova TE, Koroleva TS, Kochergina II, Matveeva LS.
    Ter Arkh; 1994 Jun; 66(10):20-1. PubMed ID: 7863437
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.